Ecolab, Purolite Resins’ Post

Ultra-low Temperature Freezers Global Market Report 2024 The ultra-low temperature freezers market size has grown strongly in recent years. It will grow from $0.87 billion in 2023 to $0.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. Read more @ https://lnkd.in/grBDX8Zq #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #UltraLowTemperatureFreezer #lowtemperaturefreezer #freezer #ChestFreezer #uprightfreezer #pharmaceuticalindustry #biotech #researchlaboratories #laboratory

The future of peptide synthesis is here! We’re excited to share our revolutionary UE-SPPS methodology, a true testament to our commitment to innovation. With the Liberty 2.0 series, we’ve eliminated the need for washing, reducing waste production by up to 95% without sacrificing yield or purity. Learn more about this game-changing technology: https://lnkd.in/erp-4FNq #Peptides #GreenChem #PeptideSynthesis #SPPS

🔍 Exploring the Advantages of Our CPG Frits! At Biocomma, we are committed to advancing oligo synthesis with our innovative CPG Frits. Here are some key benefits: 🔧 Easy to Assemble: Our CPG Frits are designed for simplicity and ease of assembly, ensuring a hassle-free setup and saving valuable time in your workflow. 📊 Consistency: Achieve reliable and repeatable results with our CPG Frits. Their consistent performance ensures high-quality production of DNA/RNA oligos every time. 🌊 Controlled Flow:  Stable flow rate improve coupling efficiency, resulting in more accurate synthesis and higher yields of full-length oligos. By reducing reagent usage, our frits offer cost savings without compromising quality. By highlighting these nuanced advantages, we aim to offer a comprehensive understanding of the benefits our CPG Frits bring to oligo synthesis processes. https://lnkd.in/gTHAzgXc  #OligoSynthesis #Biotech #Innovation #CPGfrits #oligonucleotide #CPGcolumns

By significantly cutting the amount of consumables involved in single-use biopharma processing, CultureOne adds sustainability to your production. Read more here https://lnkd.in/dQmHwwVw This example compares the total amount of plastics required for primary harvest. ➡️ Bioreactor volume: 1000 litres ➡️ Product concentration: 3 g/litre ➡️ Depth filtration system: 14 filter pods à 1.2 kg non-recyclable = 16.8 kg ➡️ CultureOne Primo: one Spinsert™ assembly, recyclable = 2.5 kg #AlfaLaval #CultureOne #Separation #Biopharma #BiopharmaProcessing #PharmaceuticalInnovation

Innovation in #singleuse technologies (SUTs) continues, however, the challenge regarding the best methods to qualify and validate single-use components remains. USP <88> / Class VI has become perceived to be a requirement by biopharmaceutical manufacturers and suppliers. However, no regulations exist that stipulate in vivo testing as a requirement for single-use technologies. Don't miss this important BioPhorum webinar on USP <88> featuring MilliporeSigma, Cytiva, Watson-Marlow Fluid Technology Solutions, Sanofi and Thermo Fisher Scientific. This webinar will give an overview of the assumed need for USP <88> / Class VI for SUT and will highlight regulatory requirements and perceived challenges to a change in testing, along with the current evidence base that demonstrates that a move away from USP <88> testing will not affect product quality or compromise patient safety. #biomanufacturing #bioprocessing Monica Cardona Nicole Hunter James Hathcock

❇Bio-Works Technologies Interim report 2023 I am happily re-sharing Bio-Works' 2023 Interim report which highlights a continued 22% sales growth, primarily driven by the company’s portfolio of high-value products: ✔ GoBio prepacked columns, custom resin solutions and affinity resins. This reflects Bio-Works belief that the market for biological therapies continues to diversify and the need for diversified purification tools is growing rapidly. ✔From a regional perspective, the North American and European markets both grew over 30%, while Asia declined during the period.  Discover how we continue to embrace the rapidly diversifying biotech industry, but also taking necessary action to secure the company's path to profitability.  #chromatography #biotech #bioprocess #dsp

Download the white paper to discover Lonza’s modular approach and gain valuable insights into the current mixing landscape. https://lnkd.in/gPm7ud_m #biopharma #lifesciences #drugdevelopment

Eliminate moisture content in a given climate with Syntec Airflow's Dehumidifier, a non-stop process that drives the moisture out of the drying agent for more moisture absorption. A controlled environment is necessary for the preparation of pharmaceutical products, as they are subjected to countless processes and are highly sensitive to temperature variations as well as humidity. #syntec #pharmatech #CuttingEdgeFacilities #coolingtower #StreamlineProcesses #costeffective #performance #innovative #dehumidifier

Download the white paper to discover Lonza’s modular approach and gain valuable insights into the current mixing landscape. https://lnkd.in/dj7irbyA #biopharma #lifesciences #drugdevelopment

Amorphous solid dispersions are a great way to tackle bioavailability limitations of poorly soluble drugs. What can be even better than them? For example, SeraNovo's proprietary formulation: a eutectic-based lipidic formulation, creatively named LiDES! Check our latest results where a LiDES formulation with exceptionally high drug loading significantly outperformed a solid dispersion! #SeraNovo #LiDES #poorlysolubledrugs #bioavailabilityenhancement #lipidformulation